AKT1 and nasopharyngeal carcinoma: To explore whether FLJ10540-induced AKT activation could affect cell motility in human NPC cells, we used AKT inhibitor to inhibit endogenous AKT activation and assayed the motility of FLJ10540-Hone1 and vehicle control cells.